ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 065,26
-1,53%
DAX
18 691,32
0,05%
Brent Oil
81,135
-0,22%
Bitcoin
67 972,74
0,07%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) Actualités

TTOO T2 Biosystems Inc

5,04
-0,59 (-10,48%)
24 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
T2 Biosystems Inc TTOO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,59 -10,48% 5,04 01:59:45
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,55 5,16 5,68 5,16 5,63
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/5/202422:49EDGAR2Form 8-K - Current report
22/5/202415:00GLOBET2 Biosystems Regains Compliance with Nasdaq Continued..
20/5/202413:00EDGAR2Form 8-K - Current report
17/5/202422:05GLOBET2 Biosystems Announces Closing of $8 Million Private..
15/5/202413:00GLOBET2 Biosystems Announces $8 Million Private Placement Priced..
14/5/202423:00GLOBET2 Biosystems Announces CRG’s Conversion from Preferred..
14/5/202422:55EDGAR2Form RW - Registration Withdrawal Request
14/5/202422:43EDGAR2Form 8-K - Current report
14/5/202401:21EDGAR2Form SC 13D/A - General statement of acquisition of..
14/5/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202401:46EDGAR2Form SC 13D/A - General statement of acquisition of..
07/5/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:48EDGAR2Form 8-K - Current report
07/5/202415:00GLOBET2 Biosystems Announces Letter of Intent to Enter Strategic..
06/5/202423:27EDGAR2Form S-1/A - General form for registration of securities..
06/5/202423:24EDGAR2Form 8-K - Current report
06/5/202423:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:34GLOBET2 Biosystems Announces First Quarter 2024 Financial Results
06/5/202422:34GLOBET2 Biosystems Announces Commercial Expansion Through Middle..
06/5/202422:29GLOBET2 Biosystems Announces the Conversion of an Additional $15..
06/5/202413:48EDGAR2Form S-1/A - General form for registration of securities..
24/4/202415:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
11/4/202422:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
28/3/202414:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20/3/202412:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
19/3/202414:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
18/3/202414:00GLOBET2 Biosystems Announces New Publication Highlighting the..
12/3/202414:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
04/3/202422:34EDGAR2Form DEF 14A - Other definitive proxy statements
27/2/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:00EDGAR2Form 8-K - Current report
15/2/202422:49EDGAR2Form PRE 14A - Other preliminary proxy statements
15/2/202422:47EDGAR2Form 8-K - Current report
15/2/202422:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
15/2/202422:04GLOBET2 Biosystems Announces Agreement with CRG for the..
15/2/202422:02GLOBET2 Biosystems Announces Commercial Expansion Through..
14/2/202402:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
07/2/202422:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
18/1/202415:00GLOBET2 Biosystems Announces Participation in NIH-funded..
05/1/202422:00EDGAR2Form 8-K - Current report
03/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:00GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand Use..

Dernières Valeurs Consultées

NASDAQ
TTOO
T2 Biosystems
TG
SPU
Snap On
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés